The
implementation guidance document shall be revised to include a
reference to the OMB control number for the information collection
contained in the guidance and PRA mandated disclosure statement.
The guidance document shall be submitted to OMB along with the
supporting statement in the next extension request.
Inventory as of this Action
Requested
Previously Approved
12/31/2007
12/31/2007
04/30/2005
11
0
140
10,860
0
7,960
0
0
0
The data captured by FDA with regard
to this Information Collection allows companies to apply for
accreditation as a third-party review of 510(k) premarket
notifications required by the FDA. Certain accredited third-party
reviewers will also be able to perform 510(k) reviews for certain
medical devices, and must submit reports of such reviews to FDA.
Third-party review is elective and at the discretion of the
manufacturer of the product.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.